Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2025-02-18 00:00:00 ET · period of report 2025-02-16 · accession 0001415889-25-004508 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-18 | 2025-02-16 | HALO | Snyder Mark Howard | SVP, CLO | M - OptEx | $0.00 | +22.2K | 27.8K | +394% | $0 |
| DM | 2025-02-18 | 2025-02-16 | HALO | Snyder Mark Howard | SVP, CLO | F - Tax | $58.29 | -12.0K | 23.0K | -34% | -$696.9K |
| DM | 2025-02-18 | 2025-02-16 | HALO | Snyder Mark Howard | SVP, CLO | M - OptEx | $0.00 | -22.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-16 | M | A | 17,409 | $0.00 | 32,411 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-16 | F | D | 2,582 | $58.29 | 25,252 | D | — | — | (F2) The reported disposition of 2,582 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| 3 | Common | Common Stock | 2025-02-16 | M | A | 4,796 | $0.00 | 27,834 | D | — | — | |
| 4 | Common | Common Stock | 2025-02-16 | F | D | 9,373 | $58.29 | 23,038 | D | — | — | (F1) The reported disposition of 9,373 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| 5 | Derivative | Restricted Stock Units | 2025-02-16 | M | D | 4,796 | $0.00 | 9,592 | D | $0.00 · — to — | 4,796 Common Stock | (F4) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |
| 6 | Derivative | Performance Stock Units | 2025-02-16 | M | D | 17,409 | $0.00 | 0 | D | $0.00 · — to — | 17,409 Common Stock | (F3) This transaction represents the vesting and settlement of performance stock units in shares of common stock of the issuer. |